Chronic Lymphocytic Leukemia Specialists in Boston, MA

Daniel Deangelo, M.D.,PH.D.

Chief, Division of Leukemia Institute Physician; Professor of Medicine, Harvard Medical School

Hematology

Eric Jacobsen, MD

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Adult Lymphoma Program; Director, Histiocyte Disorders Center

Hematology

Vincent Ho, MD

Professor of Medicine, Harvard Medical School; Director of Clinical Operations, Stem Cell Transplantation, Dana-Farber Cancer Institute

Oncology

Jorge Castillo, MD

Associate Professor at Harvard Medical School, an Institute Physician at the Dana-Farber Cancer Institute, and the Clinical Director of the Bing Center for Waldenström M; Director of the WM-NET, a consortium composed of academic researchers in the United States focused on designing and executing clinical research in patients wi

Hematology

Robert Soiffer, MD

Chief of the Division of Hematologic Malignancies; Codirector of the Adult Stem Cell Transplantation Program; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, Harvard Medical School

Oncology

Jeremy Abramson, MD

Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma, Massachusetts General Hospital Cancer Center; Associate Professor of Medicine, Harvard Medical School

Oncology

Irene Ghobrial, M.D.

Senior Vice President for Experimental Medicine, Director of the Center for Early Detection and Interception of Blood Cancers, Co-Leader of the Lymphoma/Myeloma Cancer Center Program, Lavine Family Chair for Preventative Cancer Therapies, Director of the Ghobrial Lab, and Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School

Oncology

Matthew Davids, M.D.

Director of Clinical Research, as well as Associate Director of the CLL Center. He is also an Associate Professor of Medicine at Harvard Medical School, and a; Director, Clinical Research, Division of Lymphoma

Hematology

Caron Jacobson, MD

Director, Immune Effector Cell Therapy Program; Senior Physician

Hematology

Philippe Armand, MD, PHD

Chief, Division of Lymphoma

Hematology

Jacob Soumerai, MD

Clinical Investigator in Lymphoma

Hematology

Margaret Shipp, MD

Chief of the Division of Hematologic Neoplasia at DFCI, the Director of the Lymphoma and Myeloma Program of the Dana-Farber/Harvard Cancer Center and a Pro; Chair in Lymphoma

Hematology

Andreas Klein, MD

Attending Physician and Associate Chief, Hematology Oncology; Director, Bone Marrow and Hematopoietic Cell Transplantation Program, Tufts Medical Center

Hematology

Inhye Ahn, M.D.

Associate Director of the Chronic Lymphocytic Leukemia (CLL) Center, Senior Physician, Assistant Professor of Medicine at Harvard Medical School

Oncology

Jeffrey Barnes, M.D., PH.D

Hematology

Steven Treon, Md, PhD

Director, Bing Center for Waldenström's Macroglobulinemia; Robert F. Tannenhauser Chair for Waldenström’s Research; Associate Professor (or Professor) of Medicine, Harvard Medical School

Hematology

Rupa Narayan, MD

Hematology

Antonio Giordano, M.D., PH.D

Clinical Director, Center for Cancer Therapeutic Innovation; Breast Cancer Pathways Medical Director, Dana-Farber Cancer Institute

Hematology

Reid Merryman, MD

Assistant Professor of Medicine, Harvard Medical School; Clinical Director, Follicular Lymphoma Center; Clinical Director, Marginal Zone Lymphoma Center

Oncology